Insider Stock Trading History of Ebert Charles D


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ebert Charles D since year 2005. The trader's CIK number is 1241752. At the time of this reporting, Ebert Charles D is the Development of Actavis Plc . (stock ticker symbol ACT). See this page for all insider trading activities at Actavis Plc .

Note that in the past EBERT CHARLES D also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Ebert Charles D since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-11-06 ACT Actavis Plc Sale 10,877 158.75 1,726,723
2012-02-29 WPI Watson Pharmaceuticals Inc Sale 4,981 58.79 292,837
2012-02-29 WPI Watson Pharmaceuticals Inc Option Ex 1,000 25.64 25,640
2011-06-01 WPI Watson Pharmaceuticals Inc Sale 2,635 64.45 169,825
2011-03-03 WPI Watson Pharmaceuticals Inc Option Ex 7,500 48.85 366,375
2011-03-03 WPI Watson Pharmaceuticals Inc Sale 7,500 56.36 422,700
2010-12-06 WPI Watson Pharmaceuticals Inc Sale 3,639 51.00 185,589
2010-03-12 WPI Watson Pharmaceuticals Inc Option Ex 28,600 31.45 899,555
2010-03-12 WPI Watson Pharmaceuticals Inc Sale 28,600 40.87 1,168,796
2009-12-10 WPI Watson Pharmaceuticals Inc Sale 19,000 38.25 726,750
2009-12-10 WPI Watson Pharmaceuticals Inc Option Ex 19,000 27.14 515,660
2005-12-01 WPI Watson Pharmaceuticals Inc Sale 17,000 33.28 565,726
2005-11-22 WPI Watson Pharmaceuticals Inc Sale 12,400 33.18 411,369
2005-11-17 WPI Watson Pharmaceuticals Inc Sale 15,000 32.48 487,199

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ebert Charles D (Development of Actavis Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.